nodes	percent_of_prediction	percent_of_DWPC	metapath
Bacitracin—IDE—forebrain—epilepsy syndrome	0.0202	0.0868	CbGeAlD
Bacitracin—IDE—telencephalon—epilepsy syndrome	0.0186	0.0798	CbGeAlD
Bacitracin—Albuminuria—Trimethadione—epilepsy syndrome	0.0171	0.0556	CcSEcCtD
Bacitracin—A2M—forebrain—epilepsy syndrome	0.0155	0.0668	CbGeAlD
Bacitracin—IDE—medulla oblongata—epilepsy syndrome	0.0146	0.0627	CbGeAlD
Bacitracin—A2M—telencephalon—epilepsy syndrome	0.0143	0.0614	CbGeAlD
Bacitracin—IDE—midbrain—epilepsy syndrome	0.0133	0.0573	CbGeAlD
Bacitracin—IDE—spinal cord—epilepsy syndrome	0.013	0.0559	CbGeAlD
Bacitracin—Azotaemia—Carbamazepine—epilepsy syndrome	0.0122	0.0396	CcSEcCtD
Bacitracin—IDE—head—epilepsy syndrome	0.0116	0.0497	CbGeAlD
Bacitracin—A2M—medulla oblongata—epilepsy syndrome	0.0112	0.0483	CbGeAlD
Bacitracin—IDE—nervous system—epilepsy syndrome	0.011	0.0471	CbGeAlD
Bacitracin—Albuminuria—Levetiracetam—epilepsy syndrome	0.0109	0.0353	CcSEcCtD
Bacitracin—IDE—central nervous system—epilepsy syndrome	0.0106	0.0454	CbGeAlD
Bacitracin—Albuminuria—Fosphenytoin—epilepsy syndrome	0.0105	0.034	CcSEcCtD
Bacitracin—IDE—cerebellum—epilepsy syndrome	0.0103	0.0443	CbGeAlD
Bacitracin—A2M—midbrain—epilepsy syndrome	0.0103	0.0441	CbGeAlD
Bacitracin—A2M—spinal cord—epilepsy syndrome	0.01	0.043	CbGeAlD
Bacitracin—Albuminuria—Zonisamide—epilepsy syndrome	0.00953	0.0309	CcSEcCtD
Bacitracin—Albuminuria—Phenytoin—epilepsy syndrome	0.00912	0.0296	CcSEcCtD
Bacitracin—A2M—head—epilepsy syndrome	0.0089	0.0383	CbGeAlD
Bacitracin—Albuminuria—Carbamazepine—epilepsy syndrome	0.00871	0.0283	CcSEcCtD
Bacitracin—Azotaemia—Pregabalin—epilepsy syndrome	0.00847	0.0275	CcSEcCtD
Bacitracin—A2M—nervous system—epilepsy syndrome	0.00844	0.0363	CbGeAlD
Bacitracin—IDE—brain—epilepsy syndrome	0.00838	0.036	CbGeAlD
Bacitracin—A2M—central nervous system—epilepsy syndrome	0.00813	0.0349	CbGeAlD
Bacitracin—A2M—cerebellum—epilepsy syndrome	0.00794	0.0341	CbGeAlD
Bacitracin—A2M—Degradation of the extracellular matrix—ADAM9—epilepsy syndrome	0.00674	0.0157	CbGpPWpGaD
Bacitracin—Octreotide—SSTR4—epilepsy syndrome	0.0065	0.217	CrCbGaD
Bacitracin—A2M—brain—epilepsy syndrome	0.00645	0.0277	CbGeAlD
Bacitracin—A2M—Degradation of the extracellular matrix—CAPN1—epilepsy syndrome	0.00634	0.0148	CbGpPWpGaD
Bacitracin—Albuminuria—Pregabalin—epilepsy syndrome	0.00605	0.0196	CcSEcCtD
Bacitracin—IDE—Alzheimers Disease—APOE—epilepsy syndrome	0.00588	0.0137	CbGpPWpGaD
Bacitracin—A2M—HDL-mediated lipid transport—ALB—epilepsy syndrome	0.00574	0.0134	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—FLNA—epilepsy syndrome	0.00523	0.0122	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—FLNA—epilepsy syndrome	0.00498	0.0116	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—CASP8—epilepsy syndrome	0.00495	0.0115	CbGpPWpGaD
Bacitracin—Vapreotide—SSTR5—epilepsy syndrome	0.00479	0.16	CrCbGaD
Bacitracin—A2M—Degradation of the extracellular matrix—MMP8—epilepsy syndrome	0.00467	0.0109	CbGpPWpGaD
Bacitracin—Albuminuria—Topiramate—epilepsy syndrome	0.00466	0.0151	CcSEcCtD
Bacitracin—A2M—IL6-mediated signaling events—JUNB—epilepsy syndrome	0.00463	0.0108	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—LAMP2—epilepsy syndrome	0.00462	0.0108	CbGpPWpGaD
Bacitracin—A2M—Rho GTPase cycle—ARHGEF9—epilepsy syndrome	0.00438	0.0102	CbGpPWpGaD
Bacitracin—A2M—Lipoprotein metabolism—APOE—epilepsy syndrome	0.00421	0.00981	CbGpPWpGaD
Bacitracin—Octreotide—SSTR5—epilepsy syndrome	0.00419	0.14	CrCbGaD
Bacitracin—A2M—Platelet degranulation—PPIA—epilepsy syndrome	0.00411	0.00958	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—SOCS3—epilepsy syndrome	0.00394	0.00917	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—PPIA—epilepsy syndrome	0.00392	0.00913	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—IL1B—epilepsy syndrome	0.00375	0.00874	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—CASP3—epilepsy syndrome	0.00374	0.00872	CbGpPWpGaD
Bacitracin—Octreotide—SSTR3—epilepsy syndrome	0.00373	0.124	CrCbGaD
Bacitracin—Octreotide—SSTR1—epilepsy syndrome	0.00373	0.124	CrCbGaD
Bacitracin—Vapreotide—SSTR2—epilepsy syndrome	0.00363	0.121	CrCbGaD
Bacitracin—Pain—Phenobarbital—epilepsy syndrome	0.00346	0.0112	CcSEcCtD
Bacitracin—Vomiting—Amobarbital—epilepsy syndrome	0.00342	0.0111	CcSEcCtD
Bacitracin—Rash—Amobarbital—epilepsy syndrome	0.0034	0.011	CcSEcCtD
Bacitracin—Dermatitis—Amobarbital—epilepsy syndrome	0.00339	0.011	CcSEcCtD
Bacitracin—Vomiting—Primidone—epilepsy syndrome	0.0033	0.0107	CcSEcCtD
Bacitracin—A2M—Lipoprotein metabolism—ALB—epilepsy syndrome	0.0033	0.00768	CbGpPWpGaD
Bacitracin—Rash—Primidone—epilepsy syndrome	0.00327	0.0106	CcSEcCtD
Bacitracin—Dermatitis—Primidone—epilepsy syndrome	0.00327	0.0106	CcSEcCtD
Bacitracin—Nausea—Amobarbital—epilepsy syndrome	0.0032	0.0104	CcSEcCtD
Bacitracin—Octreotide—SSTR2—epilepsy syndrome	0.00317	0.106	CrCbGaD
Bacitracin—Nausea—Primidone—epilepsy syndrome	0.00308	0.01	CcSEcCtD
Bacitracin—A2M—IL6-mediated signaling events—CRP—epilepsy syndrome	0.00301	0.007	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—DOCK7—epilepsy syndrome	0.00292	0.0068	CbGpPWpGaD
Bacitracin—Vomiting—Trimethadione—epilepsy syndrome	0.0029	0.00942	CcSEcCtD
Bacitracin—Rash—Trimethadione—epilepsy syndrome	0.00288	0.00935	CcSEcCtD
Bacitracin—Dermatitis—Trimethadione—epilepsy syndrome	0.00288	0.00934	CcSEcCtD
Bacitracin—A2M—Extracellular matrix organization—ADAM9—epilepsy syndrome	0.00282	0.00658	CbGpPWpGaD
Bacitracin—A2M—Lipid and lipoprotein metabolism—APOE—epilepsy syndrome	0.0028	0.00652	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—IL6ST—epilepsy syndrome	0.00276	0.00643	CbGpPWpGaD
Bacitracin—IDE—Alzheimers Disease—TNF—epilepsy syndrome	0.00272	0.00634	CbGpPWpGaD
Bacitracin—Nausea—Trimethadione—epilepsy syndrome	0.00271	0.0088	CcSEcCtD
Bacitracin—A2M—Extracellular matrix organization—CAPN1—epilepsy syndrome	0.00265	0.00618	CbGpPWpGaD
Bacitracin—Vomiting—Phenobarbital—epilepsy syndrome	0.00257	0.00835	CcSEcCtD
Bacitracin—Pain—Propofol—epilepsy syndrome	0.00256	0.00831	CcSEcCtD
Bacitracin—Rash—Phenobarbital—epilepsy syndrome	0.00255	0.00828	CcSEcCtD
Bacitracin—Dermatitis—Phenobarbital—epilepsy syndrome	0.00255	0.00827	CcSEcCtD
Bacitracin—A2M—IL6-mediated signaling events—FOS—epilepsy syndrome	0.00253	0.00589	CbGpPWpGaD
Bacitracin—Vomiting—Rufinamide—epilepsy syndrome	0.00252	0.00819	CcSEcCtD
Bacitracin—A2M—Degradation of the extracellular matrix—ADAM10—epilepsy syndrome	0.00252	0.00588	CbGpPWpGaD
Bacitracin—Pain—Midazolam—epilepsy syndrome	0.0025	0.00813	CcSEcCtD
Bacitracin—Rash—Rufinamide—epilepsy syndrome	0.0025	0.00812	CcSEcCtD
Bacitracin—Dermatitis—Rufinamide—epilepsy syndrome	0.0025	0.00812	CcSEcCtD
Bacitracin—Pain—Levetiracetam—epilepsy syndrome	0.00247	0.00803	CcSEcCtD
Bacitracin—Nausea—Phenobarbital—epilepsy syndrome	0.0024	0.0078	CcSEcCtD
Bacitracin—A2M—Hemostasis—LAMP2—epilepsy syndrome	0.00238	0.00555	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	0.00237	0.00552	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	0.00237	0.00552	CbGpPWpGaD
Bacitracin—Vomiting—Lacosamide—epilepsy syndrome	0.00237	0.00769	CcSEcCtD
Bacitracin—Nausea—Rufinamide—epilepsy syndrome	0.00236	0.00765	CcSEcCtD
Bacitracin—Rash—Lacosamide—epilepsy syndrome	0.00235	0.00763	CcSEcCtD
Bacitracin—Dermatitis—Lacosamide—epilepsy syndrome	0.00235	0.00762	CcSEcCtD
Bacitracin—Pain—Vigabatrin—epilepsy syndrome	0.00233	0.00756	CcSEcCtD
Bacitracin—A2M—Platelet activation, signaling and aggregation—FLNA—epilepsy syndrome	0.00232	0.0054	CbGpPWpGaD
Bacitracin—Vomiting—Clobazam—epilepsy syndrome	0.0023	0.00747	CcSEcCtD
Bacitracin—Pain—Diazepam—epilepsy syndrome	0.00229	0.00744	CcSEcCtD
Bacitracin—Rash—Clobazam—epilepsy syndrome	0.00228	0.0074	CcSEcCtD
Bacitracin—Dermatitis—Clobazam—epilepsy syndrome	0.00228	0.0074	CcSEcCtD
Bacitracin—Pain—Felbamate—epilepsy syndrome	0.00222	0.0072	CcSEcCtD
Bacitracin—Nausea—Lacosamide—epilepsy syndrome	0.00221	0.00719	CcSEcCtD
Bacitracin—A2M—Lipid and lipoprotein metabolism—ALB—epilepsy syndrome	0.00219	0.00511	CbGpPWpGaD
Bacitracin—Nausea—Clobazam—epilepsy syndrome	0.00215	0.00697	CcSEcCtD
Bacitracin—Pain—Clonazepam—epilepsy syndrome	0.00209	0.00679	CcSEcCtD
Bacitracin—Pain—Oxcarbazepine—epilepsy syndrome	0.00207	0.00671	CcSEcCtD
Bacitracin—Vomiting—Acetazolamide—epilepsy syndrome	0.00205	0.00665	CcSEcCtD
Bacitracin—A2M—Extracellular matrix organization—DMD—epilepsy syndrome	0.00201	0.00469	CbGpPWpGaD
Bacitracin—Pain—Carbamazepine—epilepsy syndrome	0.00198	0.00644	CcSEcCtD
Bacitracin—A2M—Hemostasis—SLC8A2—epilepsy syndrome	0.00197	0.0046	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—MMP8—epilepsy syndrome	0.00196	0.00456	CbGpPWpGaD
Bacitracin—Pain—Lamotrigine—epilepsy syndrome	0.00192	0.00622	CcSEcCtD
Bacitracin—Nausea—Acetazolamide—epilepsy syndrome	0.00191	0.00622	CcSEcCtD
Bacitracin—Vomiting—Propofol—epilepsy syndrome	0.0019	0.00618	CcSEcCtD
Bacitracin—Rash—Propofol—epilepsy syndrome	0.00189	0.00613	CcSEcCtD
Bacitracin—Dermatitis—Propofol—epilepsy syndrome	0.00189	0.00612	CcSEcCtD
Bacitracin—A2M—Hemostasis—SLC8A3—epilepsy syndrome	0.00188	0.00439	CbGpPWpGaD
Bacitracin—A2M—Rho GTPase cycle—CDC42—epilepsy syndrome	0.00188	0.00438	CbGpPWpGaD
Bacitracin—Vomiting—Midazolam—epilepsy syndrome	0.00186	0.00605	CcSEcCtD
Bacitracin—Rash—Midazolam—epilepsy syndrome	0.00185	0.006	CcSEcCtD
Bacitracin—Dermatitis—Midazolam—epilepsy syndrome	0.00185	0.00599	CcSEcCtD
Bacitracin—Vomiting—Levetiracetam—epilepsy syndrome	0.00184	0.00597	CcSEcCtD
Bacitracin—A2M—Platelet activation, signaling and aggregation—PPIA—epilepsy syndrome	0.00182	0.00425	CbGpPWpGaD
Bacitracin—Rash—Levetiracetam—epilepsy syndrome	0.00182	0.00592	CcSEcCtD
Bacitracin—Dermatitis—Levetiracetam—epilepsy syndrome	0.00182	0.00592	CcSEcCtD
Bacitracin—A2M—IL6-mediated signaling events—JUN—epilepsy syndrome	0.00182	0.00423	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	0.0018	0.00418	CbGpPWpGaD
Bacitracin—Nausea—Propofol—epilepsy syndrome	0.00178	0.00577	CcSEcCtD
Bacitracin—Vomiting—Fosphenytoin—epilepsy syndrome	0.00178	0.00576	CcSEcCtD
Bacitracin—Rash—Fosphenytoin—epilepsy syndrome	0.00176	0.00572	CcSEcCtD
Bacitracin—Dermatitis—Fosphenytoin—epilepsy syndrome	0.00176	0.00571	CcSEcCtD
Bacitracin—Nausea—Midazolam—epilepsy syndrome	0.00174	0.00565	CcSEcCtD
Bacitracin—Vomiting—Vigabatrin—epilepsy syndrome	0.00173	0.00562	CcSEcCtD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—PRKCB—epilepsy syndrome	0.00173	0.00402	CbGpPWpGaD
Bacitracin—Nausea—Levetiracetam—epilepsy syndrome	0.00172	0.00558	CcSEcCtD
Bacitracin—Rash—Vigabatrin—epilepsy syndrome	0.00172	0.00557	CcSEcCtD
Bacitracin—Dermatitis—Vigabatrin—epilepsy syndrome	0.00171	0.00557	CcSEcCtD
Bacitracin—Vomiting—Diazepam—epilepsy syndrome	0.0017	0.00553	CcSEcCtD
Bacitracin—Rash—Diazepam—epilepsy syndrome	0.00169	0.00548	CcSEcCtD
Bacitracin—Dermatitis—Diazepam—epilepsy syndrome	0.00169	0.00548	CcSEcCtD
Bacitracin—Nausea—Fosphenytoin—epilepsy syndrome	0.00166	0.00538	CcSEcCtD
Bacitracin—Vomiting—Felbamate—epilepsy syndrome	0.00165	0.00535	CcSEcCtD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	0.00164	0.00383	CbGpPWpGaD
Bacitracin—Rash—Felbamate—epilepsy syndrome	0.00163	0.00531	CcSEcCtD
Bacitracin—Dermatitis—Felbamate—epilepsy syndrome	0.00163	0.0053	CcSEcCtD
Bacitracin—Nausea—Vigabatrin—epilepsy syndrome	0.00162	0.00525	CcSEcCtD
Bacitracin—Vomiting—Zonisamide—epilepsy syndrome	0.00161	0.00524	CcSEcCtD
Bacitracin—Rash—Zonisamide—epilepsy syndrome	0.0016	0.0052	CcSEcCtD
Bacitracin—Dermatitis—Zonisamide—epilepsy syndrome	0.0016	0.00519	CcSEcCtD
Bacitracin—Nausea—Diazepam—epilepsy syndrome	0.00159	0.00517	CcSEcCtD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	0.00158	0.00368	CbGpPWpGaD
Bacitracin—Vomiting—Clonazepam—epilepsy syndrome	0.00156	0.00505	CcSEcCtD
Bacitracin—Vomiting—Phenytoin—epilepsy syndrome	0.00154	0.00502	CcSEcCtD
Bacitracin—Rash—Clonazepam—epilepsy syndrome	0.00154	0.00501	CcSEcCtD
Bacitracin—Dermatitis—Clonazepam—epilepsy syndrome	0.00154	0.005	CcSEcCtD
Bacitracin—Nausea—Felbamate—epilepsy syndrome	0.00154	0.005	CcSEcCtD
Bacitracin—Vomiting—Oxcarbazepine—epilepsy syndrome	0.00154	0.00499	CcSEcCtD
Bacitracin—Rash—Phenytoin—epilepsy syndrome	0.00153	0.00497	CcSEcCtD
Bacitracin—Dermatitis—Phenytoin—epilepsy syndrome	0.00153	0.00497	CcSEcCtD
Bacitracin—Rash—Oxcarbazepine—epilepsy syndrome	0.00152	0.00495	CcSEcCtD
Bacitracin—Pain—Valproic Acid—epilepsy syndrome	0.00152	0.00495	CcSEcCtD
Bacitracin—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.00152	0.00494	CcSEcCtD
Bacitracin—Nausea—Zonisamide—epilepsy syndrome	0.00151	0.0049	CcSEcCtD
Bacitracin—A2M—Platelet degranulation—ALB—epilepsy syndrome	0.00151	0.00351	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—BMP4—epilepsy syndrome	0.00148	0.00346	CbGpPWpGaD
Bacitracin—Vomiting—Carbamazepine—epilepsy syndrome	0.00147	0.00479	CcSEcCtD
Bacitracin—Rash—Carbamazepine—epilepsy syndrome	0.00146	0.00475	CcSEcCtD
Bacitracin—Dermatitis—Carbamazepine—epilepsy syndrome	0.00146	0.00474	CcSEcCtD
Bacitracin—Nausea—Clonazepam—epilepsy syndrome	0.00145	0.00472	CcSEcCtD
Bacitracin—Nausea—Phenytoin—epilepsy syndrome	0.00144	0.00469	CcSEcCtD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	0.00144	0.00335	CbGpPWpGaD
Bacitracin—Nausea—Oxcarbazepine—epilepsy syndrome	0.00144	0.00466	CcSEcCtD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—ALB—epilepsy syndrome	0.00143	0.00334	CbGpPWpGaD
Bacitracin—Vomiting—Lamotrigine—epilepsy syndrome	0.00143	0.00463	CcSEcCtD
Bacitracin—A2M—Platelet activation, signaling and aggregation—ADRA2A—epilepsy syndrome	0.00142	0.00331	CbGpPWpGaD
Bacitracin—Rash—Lamotrigine—epilepsy syndrome	0.00141	0.00459	CcSEcCtD
Bacitracin—Dermatitis—Lamotrigine—epilepsy syndrome	0.00141	0.00458	CcSEcCtD
Bacitracin—A2M—Extracellular matrix organization—ITGA2—epilepsy syndrome	0.0014	0.00327	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CA13—epilepsy syndrome	0.00139	0.00324	CbGpPWpGaD
Bacitracin—Nausea—Carbamazepine—epilepsy syndrome	0.00138	0.00447	CcSEcCtD
Bacitracin—Pain—Pregabalin—epilepsy syndrome	0.00138	0.00447	CcSEcCtD
Bacitracin—Nausea—Lamotrigine—epilepsy syndrome	0.00133	0.00432	CcSEcCtD
Bacitracin—A2M—Hemostasis—TEK—epilepsy syndrome	0.00127	0.00296	CbGpPWpGaD
Bacitracin—Pain—Gabapentin—epilepsy syndrome	0.00126	0.0041	CcSEcCtD
Bacitracin—A2M—Platelet activation, signaling and aggregation—AKT3—epilepsy syndrome	0.00125	0.00291	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—FLNA—epilepsy syndrome	0.0012	0.00278	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—CDC42—epilepsy syndrome	0.00114	0.00265	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—KCNMA1—epilepsy syndrome	0.00113	0.00264	CbGpPWpGaD
Bacitracin—Vomiting—Valproic Acid—epilepsy syndrome	0.00113	0.00368	CcSEcCtD
Bacitracin—Rash—Valproic Acid—epilepsy syndrome	0.00112	0.00365	CcSEcCtD
Bacitracin—A2M—Degradation of the extracellular matrix—CASP3—epilepsy syndrome	0.00112	0.00261	CbGpPWpGaD
Bacitracin—Dermatitis—Valproic Acid—epilepsy syndrome	0.00112	0.00364	CcSEcCtD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	0.00112	0.00261	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—SLC8A1—epilepsy syndrome	0.00112	0.00261	CbGpPWpGaD
Bacitracin—Pain—Topiramate—epilepsy syndrome	0.00106	0.00345	CcSEcCtD
Bacitracin—A2M—Degradation of the extracellular matrix—MMP9—epilepsy syndrome	0.00106	0.00247	CbGpPWpGaD
Bacitracin—Nausea—Valproic Acid—epilepsy syndrome	0.00106	0.00344	CcSEcCtD
Bacitracin—A2M—Extracellular matrix organization—ADAM10—epilepsy syndrome	0.00106	0.00246	CbGpPWpGaD
Bacitracin—A2M—Metabolism—FAR1—epilepsy syndrome	0.00106	0.00246	CbGpPWpGaD
Bacitracin—A2M—Metabolism—L2HGDH—epilepsy syndrome	0.00106	0.00246	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ADK—epilepsy syndrome	0.00106	0.00246	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PDXK—epilepsy syndrome	0.00106	0.00246	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CERS1—epilepsy syndrome	0.00106	0.00246	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GLUD1—epilepsy syndrome	0.00106	0.00246	CbGpPWpGaD
Bacitracin—A2M—Platelet degranulation—VEGFA—epilepsy syndrome	0.00104	0.00242	CbGpPWpGaD
Bacitracin—Vomiting—Pregabalin—epilepsy syndrome	0.00102	0.00332	CcSEcCtD
Bacitracin—Rash—Pregabalin—epilepsy syndrome	0.00102	0.0033	CcSEcCtD
Bacitracin—Dermatitis—Pregabalin—epilepsy syndrome	0.00101	0.00329	CcSEcCtD
Bacitracin—A2M—Platelet activation, signaling and aggregation—FYN—epilepsy syndrome	0.00101	0.00236	CbGpPWpGaD
Bacitracin—A2M—IL6-mediated signaling events—AKT1—epilepsy syndrome	0.00101	0.00236	CbGpPWpGaD
Bacitracin—A2M—Response to elevated platelet cytosolic Ca2+—VEGFA—epilepsy syndrome	0.000988	0.0023	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—YWHAZ—epilepsy syndrome	0.000974	0.00227	CbGpPWpGaD
Bacitracin—A2M—Metabolism—EPM2A—epilepsy syndrome	0.000966	0.00225	CbGpPWpGaD
Bacitracin—A2M—Metabolism—NHLRC1—epilepsy syndrome	0.000966	0.00225	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GAMT—epilepsy syndrome	0.000966	0.00225	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PNPO—epilepsy syndrome	0.000966	0.00225	CbGpPWpGaD
Bacitracin—Nausea—Pregabalin—epilepsy syndrome	0.000956	0.00311	CcSEcCtD
Bacitracin—A2M—Hemostasis—PPIA—epilepsy syndrome	0.000941	0.00219	CbGpPWpGaD
Bacitracin—Vomiting—Gabapentin—epilepsy syndrome	0.000939	0.00305	CcSEcCtD
Bacitracin—Rash—Gabapentin—epilepsy syndrome	0.000931	0.00302	CcSEcCtD
Bacitracin—Dermatitis—Gabapentin—epilepsy syndrome	0.00093	0.00302	CcSEcCtD
Bacitracin—A2M—Metabolism—QDPR—epilepsy syndrome	0.000898	0.00209	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CA4—epilepsy syndrome	0.000898	0.00209	CbGpPWpGaD
Bacitracin—Nausea—Gabapentin—epilepsy syndrome	0.000877	0.00285	CcSEcCtD
Bacitracin—A2M—Hemostasis—ATP2A2—epilepsy syndrome	0.000859	0.002	CbGpPWpGaD
Bacitracin—A2M—Metabolism—COX3—epilepsy syndrome	0.000844	0.00197	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—ITGA2—epilepsy syndrome	0.000834	0.00194	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.000807	0.00188	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PRDM4—epilepsy syndrome	0.000807	0.00188	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—PRKCB—epilepsy syndrome	0.000804	0.00187	CbGpPWpGaD
Bacitracin—A2M—Metabolism—KCNB1—epilepsy syndrome	0.0008	0.00186	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PFKL—epilepsy syndrome	0.0008	0.00186	CbGpPWpGaD
Bacitracin—A2M—Metabolism—SLCO1A2—epilepsy syndrome	0.0008	0.00186	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CACNA2D2—epilepsy syndrome	0.0008	0.00186	CbGpPWpGaD
Bacitracin—A2M—Metabolism—SLC6A8—epilepsy syndrome	0.0008	0.00186	CbGpPWpGaD
Bacitracin—Vomiting—Topiramate—epilepsy syndrome	0.00079	0.00256	CcSEcCtD
Bacitracin—Rash—Topiramate—epilepsy syndrome	0.000783	0.00254	CcSEcCtD
Bacitracin—Dermatitis—Topiramate—epilepsy syndrome	0.000783	0.00254	CcSEcCtD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	0.000782	0.00182	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	0.000777	0.00181	CbGpPWpGaD
Bacitracin—Nausea—Topiramate—epilepsy syndrome	0.000738	0.0024	CcSEcCtD
Bacitracin—A2M—Hemostasis—ADRA2A—epilepsy syndrome	0.000733	0.00171	CbGpPWpGaD
Bacitracin—A2M—Metabolism—UPB1—epilepsy syndrome	0.000732	0.0017	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ATIC—epilepsy syndrome	0.000732	0.0017	CbGpPWpGaD
Bacitracin—A2M—Metabolism—NEU1—epilepsy syndrome	0.000732	0.0017	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—PLAT—epilepsy syndrome	0.00073	0.0017	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—KDR—epilepsy syndrome	0.000724	0.00169	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ACKR4—epilepsy syndrome	0.000706	0.00164	CbGpPWpGaD
Bacitracin—A2M—Metabolism—HSD17B4—epilepsy syndrome	0.000704	0.00164	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—NOS1—epilepsy syndrome	0.000687	0.0016	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GBE1—epilepsy syndrome	0.00068	0.00158	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PPP1R3C—epilepsy syndrome	0.00068	0.00158	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—ALB—epilepsy syndrome	0.000668	0.00156	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	0.000665	0.00155	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—AKT3—epilepsy syndrome	0.000643	0.0015	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ASAH1—epilepsy syndrome	0.00064	0.00149	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SSTR4—epilepsy syndrome	0.000638	0.00149	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SSTR5—epilepsy syndrome	0.000638	0.00149	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—PLAUR—epilepsy syndrome	0.000635	0.00148	CbGpPWpGaD
Bacitracin—A2M—Metabolism—STXBP1—epilepsy syndrome	0.000622	0.00145	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CCR10—epilepsy syndrome	0.000612	0.00143	CbGpPWpGaD
Bacitracin—A2M—Metabolism—NT5E—epilepsy syndrome	0.000606	0.00141	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ALAD—epilepsy syndrome	0.000606	0.00141	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—CDC42—epilepsy syndrome	0.000587	0.00137	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ALDH7A1—epilepsy syndrome	0.000578	0.00135	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CACNA1A—epilepsy syndrome	0.000578	0.00135	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ST3GAL3—epilepsy syndrome	0.000566	0.00132	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—FGF2—epilepsy syndrome	0.000562	0.00131	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ADSL—epilepsy syndrome	0.000555	0.00129	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GLUL—epilepsy syndrome	0.000544	0.00127	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GRM2—epilepsy syndrome	0.000535	0.00125	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CACNA1D—epilepsy syndrome	0.000534	0.00124	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—FYN—epilepsy syndrome	0.000522	0.00122	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—YWHAZ—epilepsy syndrome	0.000502	0.00117	CbGpPWpGaD
Bacitracin—A2M—Metabolism—TXNRD1—epilepsy syndrome	0.000499	0.00116	CbGpPWpGaD
Bacitracin—A2M—Metabolism—AQP1—epilepsy syndrome	0.000485	0.00113	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SSTR3—epilepsy syndrome	0.000484	0.00113	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000473	0.0011	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	0.000472	0.0011	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—CASP3—epilepsy syndrome	0.00047	0.0011	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	0.000466	0.00108	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000464	0.00108	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NPY2R—epilepsy syndrome	0.000464	0.00108	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CCR9—epilepsy syndrome	0.000464	0.00108	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SSTR1—epilepsy syndrome	0.000464	0.00108	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CCR8—epilepsy syndrome	0.000464	0.00108	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	0.00046	0.00107	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GRM4—epilepsy syndrome	0.000455	0.00106	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GRM3—epilepsy syndrome	0.000455	0.00106	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—DUSP4—epilepsy syndrome	0.000446	0.00104	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SSTR2—epilepsy syndrome	0.000446	0.00104	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—PLAU—epilepsy syndrome	0.000446	0.00104	CbGpPWpGaD
Bacitracin—A2M—Extracellular matrix organization—MMP9—epilepsy syndrome	0.000444	0.00104	CbGpPWpGaD
Bacitracin—A2M—Metabolism—KCNJ11—epilepsy syndrome	0.000438	0.00102	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CHRM3—epilepsy syndrome	0.000438	0.00102	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GRM8—epilepsy syndrome	0.000431	0.001	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PGF—epilepsy syndrome	0.000431	0.001	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—PRKCB—epilepsy syndrome	0.000414	0.000965	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GNAO1—epilepsy syndrome	0.000411	0.000958	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—OPRD1—epilepsy syndrome	0.000411	0.000958	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—NOS2—epilepsy syndrome	0.000409	0.000954	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	0.000408	0.000951	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	0.0004	0.000932	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CHRM1—epilepsy syndrome	0.000394	0.000918	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GRM1—epilepsy syndrome	0.000394	0.000918	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PDYN—epilepsy syndrome	0.000394	0.000918	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CCR7—epilepsy syndrome	0.000394	0.000918	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GFAP—epilepsy syndrome	0.000371	0.000864	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GAL—epilepsy syndrome	0.000371	0.000864	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CASP2—epilepsy syndrome	0.000367	0.000854	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CHRM3—epilepsy syndrome	0.000367	0.000854	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GRM5—epilepsy syndrome	0.000367	0.000854	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ABCG2—epilepsy syndrome	0.000357	0.000832	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000351	0.000819	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CYP2C19—epilepsy syndrome	0.000348	0.000811	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CYP11A1—epilepsy syndrome	0.000346	0.000806	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000345	0.000803	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000345	0.000803	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CHRM2—epilepsy syndrome	0.000345	0.000803	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—ALB—epilepsy syndrome	0.000344	0.000802	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	0.000344	0.0008	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—GABBR1—epilepsy syndrome	0.000335	0.000781	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HRH3—epilepsy syndrome	0.000321	0.000749	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—OPRM1—epilepsy syndrome	0.000316	0.000737	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	0.000313	0.00073	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CYP2D6—epilepsy syndrome	0.000312	0.000728	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CCR3—epilepsy syndrome	0.000299	0.000696	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ADRA2A—epilepsy syndrome	0.000297	0.000693	CbGpPWpGaD
Bacitracin—A2M—Metabolism—BCHE—epilepsy syndrome	0.000296	0.00069	CbGpPWpGaD
Bacitracin—A2M—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	0.000294	0.000684	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000291	0.000678	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NPY—epilepsy syndrome	0.000291	0.000678	CbGpPWpGaD
Bacitracin—A2M—Metabolism—SLC2A1—epilepsy syndrome	0.000283	0.000658	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HSPB1—epilepsy syndrome	0.000281	0.000654	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CRH—epilepsy syndrome	0.000281	0.000654	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—OXT—epilepsy syndrome	0.000281	0.000654	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CCL3—epilepsy syndrome	0.000281	0.000654	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CXCL2—epilepsy syndrome	0.000281	0.000654	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PLCB1—epilepsy syndrome	0.000279	0.000651	CbGpPWpGaD
Bacitracin—A2M—Metabolism—TH—epilepsy syndrome	0.000278	0.000649	CbGpPWpGaD
Bacitracin—A2M—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	0.000274	0.000638	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TSC1—epilepsy syndrome	0.000261	0.000608	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PTK2B—epilepsy syndrome	0.000261	0.000608	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CCR2—epilepsy syndrome	0.000254	0.000592	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NTRK2—epilepsy syndrome	0.000254	0.000592	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SST—epilepsy syndrome	0.000254	0.000592	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—DUSP6—epilepsy syndrome	0.000252	0.000587	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000249	0.000579	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PLAT—epilepsy syndrome	0.000248	0.000577	CbGpPWpGaD
Bacitracin—Desmopressin—PTGS2—epilepsy syndrome	0.000247	0.00822	CrCbGaD
Bacitracin—A2M—Hemostasis—SRC—epilepsy syndrome	0.000243	0.000567	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CXCL12—epilepsy syndrome	0.000239	0.000556	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000239	0.000556	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—VEGFA—epilepsy syndrome	0.000237	0.000552	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—JUNB—epilepsy syndrome	0.000234	0.000546	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CNR1—epilepsy syndrome	0.000234	0.000546	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PLCB1—epilepsy syndrome	0.000234	0.000544	CbGpPWpGaD
Bacitracin—A2M—Metabolism—HMOX1—epilepsy syndrome	0.000232	0.000541	CbGpPWpGaD
Bacitracin—A2M—Metabolism—CAT—epilepsy syndrome	0.000229	0.000534	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HTR7—epilepsy syndrome	0.000229	0.000533	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ABCB1—epilepsy syndrome	0.000223	0.00052	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HBEGF—epilepsy syndrome	0.000222	0.000517	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—AKT3—epilepsy syndrome	0.000218	0.000508	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—ADAM10—epilepsy syndrome	0.000213	0.000496	CbGpPWpGaD
Bacitracin—A2M—Metabolism—GPX1—epilepsy syndrome	0.000207	0.000483	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—S100B—epilepsy syndrome	0.000201	0.000469	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SOCS3—epilepsy syndrome	0.000199	0.000464	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CDC42—epilepsy syndrome	0.000199	0.000463	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—AVP—epilepsy syndrome	0.000193	0.000449	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HES1—epilepsy syndrome	0.000182	0.000424	CbGpPWpGaD
Bacitracin—A2M—Metabolism—AGT—epilepsy syndrome	0.000182	0.000423	CbGpPWpGaD
Bacitracin—A2M—Metabolism—APOE—epilepsy syndrome	0.000178	0.000415	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FYN—epilepsy syndrome	0.000177	0.000412	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—H2AFX—epilepsy syndrome	0.000176	0.000411	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MEF2C—epilepsy syndrome	0.000176	0.00041	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—YWHAZ—epilepsy syndrome	0.00017	0.000396	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—NGF—epilepsy syndrome	0.000168	0.000392	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CCR5—epilepsy syndrome	0.000164	0.000381	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—HTR2A—epilepsy syndrome	0.00016	0.000373	CbGpPWpGaD
Bacitracin—A2M—Metabolism—POMC—epilepsy syndrome	0.000153	0.000356	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—TSC2—epilepsy syndrome	0.000152	0.000355	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—AGT—epilepsy syndrome	0.000152	0.000354	CbGpPWpGaD
Bacitracin—A2M—Hemostasis—AKT1—epilepsy syndrome	0.000151	0.000352	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—APOE—epilepsy syndrome	0.000149	0.000347	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—KDR—epilepsy syndrome	0.000146	0.00034	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—PRKCB—epilepsy syndrome	0.00014	0.000327	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—IL6ST—epilepsy syndrome	0.00014	0.000326	CbGpPWpGaD
Bacitracin—A2M—Metabolism—ALB—epilepsy syndrome	0.00014	0.000325	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—POMC—epilepsy syndrome	0.000128	0.000298	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CCL2—epilepsy syndrome	0.000125	0.000292	CbGpPWpGaD
Bacitracin—A2M—Metabolism—PTGS2—epilepsy syndrome	0.000122	0.000284	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—FGF2—epilepsy syndrome	0.000113	0.000264	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—RELA—epilepsy syndrome	0.000105	0.000245	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MTOR—epilepsy syndrome	0.000103	0.00024	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—CASP3—epilepsy syndrome	9.47e-05	0.000221	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—JUN—epilepsy syndrome	9.2e-05	0.000214	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—MMP9—epilepsy syndrome	8.95e-05	0.000209	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—SRC—epilepsy syndrome	8.26e-05	0.000192	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—VEGFA—epilepsy syndrome	8.04e-05	0.000187	CbGpPWpGaD
Bacitracin—A2M—Metabolism—AKT1—epilepsy syndrome	6.14e-05	0.000143	CbGpPWpGaD
Bacitracin—A2M—Signaling Pathways—AKT1—epilepsy syndrome	5.13e-05	0.000119	CbGpPWpGaD
